tiprankstipranks
Trending News
More News >

Arvinas Elects New Directors and Ratifies Auditor

Story Highlights
Arvinas Elects New Directors and Ratifies Auditor

Don’t Miss TipRanks’ Half-Year Sale

Arvinas Holding Company ( (ARVN) ) just unveiled an update.

At the annual meeting held on June 25, 2025, Arvinas Holding Company stockholders elected new Class I directors to the board, approved a non-binding advisory proposal on executive compensation, and ratified Deloitte & Touche LLP as the independent accounting firm for the fiscal year ending December 31, 2025. These decisions reflect the company’s ongoing governance and financial oversight strategies, potentially impacting its operational stability and stakeholder confidence.

The most recent analyst rating on (ARVN) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Arvinas Holding Company stock, see the ARVN Stock Forecast page.

Spark’s Take on ARVN Stock

According to Spark, TipRanks’ AI Analyst, ARVN is a Neutral.

The overall stock score reflects a blend of strong revenue growth and positive strategic initiatives, offset by profitability challenges and mixed technical indicators. The company’s strong cash position and promising clinical pipeline contribute positively, while valuation concerns and restructuring efforts present risks.

To see Spark’s full report on ARVN stock, click here.

More about Arvinas Holding Company

Average Trading Volume: 2,643,533

Technical Sentiment Signal: Sell

Current Market Cap: $550.4M

See more insights into ARVN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1